The online version of this article (doi:10.1186/1752-1947-6-374) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
CHJ and JOM contributed to patients’ diagnosis and treatment. HJG and BYK participated in the literature review. JMP and HSH contributed to radiology-related issues and JJK contributed to histology-related issues. CHK and SKK participated in interpretation of the case. All authors read and approved the manuscript.
When a pulmonary nodular lesion is detected by F-18 fluorodeoxyglucose positron emission tomography-computed tomography in a patient with post-surgical papillary thyroid carcinoma with undetectable serum-stimulated thyroglobulin levels and negative 131I whole body scan, diagnosis and management of the nodule may be confusing.
We describe two post-surgical patients with papillary thyroid carcinoma who showed pulmonary nodular lesions detected by F-18 fluorodeoxyglucose positron emission tomography-computed tomography. In both cases serum-stimulated thyroglobulin levels were undetectable and nodular lesions were not detected by 131I whole body scan. In the first case, a 64-year-old Asian woman showed one focal increased fluorodeoxyglucose uptake lesion in the right lower lobe of one of her lungs. Based on the histologic study, the pulmonary nodular lesion was diagnosed as a solitary pulmonary metastasis from papillary thyroid carcinoma. In the second case, a 59-year-old Asian woman showed a new pulmonary nodule in the right lower lobe. The computed tomography scan of her chest revealed a 9mm nodule in the anterior basal segment and another tiny nodule in the posterior basal segment of the right lower lobe. Six months later, both nodules had increased in size and miliary disseminated nodules were also seen in both lungs. Based on their histology, the pulmonary nodular lesions were considered to be primary lung adenocarcinoma.
The present cases emphasize that physicians should be cautious and make efforts for an accurate diagnosis of pulmonary nodules detected on F-18 fluorodeoxyglucose positron emission tomography-computed tomography in patients with papillary thyroid carcinoma with no evidence of metastasis such as negative 131I whole body scan and undetectable stimulated serum thyroglobulin levels.
Authors’ original file for figure 113256_2012_2315_MOESM1_ESM.tiff
Authors’ original file for figure 213256_2012_2315_MOESM2_ESM.tiff
Authors’ original file for figure 313256_2012_2315_MOESM3_ESM.tiff
Authors’ original file for figure 413256_2012_2315_MOESM4_ESM.tiff
Authors’ original file for figure 513256_2012_2315_MOESM5_ESM.ppt
Authors’ original file for figure 613256_2012_2315_MOESM6_ESM.ppt
Authors’ original file for figure 713256_2012_2315_MOESM7_ESM.ppt
Authors’ original file for figure 813256_2012_2315_MOESM8_ESM.ppt
Authors’ original file for figure 913256_2012_2315_MOESM9_ESM.ppt
Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travaqli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M: Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006, 91: 2892-2899. 10.1210/jc.2005-2838. CrossRefPubMed
Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM, American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009, 19: 1167-1214. 10.1089/thy.2009.0110. CrossRefPubMed
Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY: Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med. 1999, 40: 986-992. PubMed
Lee JH, Ahn SJ, Kim HJ, Jang SE, Koh JS, Lee YY, Kim CH, Lee JC: Solitary pulmonary metastasis of a thyroid papillary microcarcinoma, masquerading as primary lung cancer. Endocrinol Metab. 2011, 26: 78-83. 10.3803/EnM.2011.26.1.78. CrossRef
Nakada K, Shinohara K, Takei T, Omatsu T, Kamishima T, Onodera Y, Tamaki N, Miyasaka K: Non-typical lung nodules in patients with post-surgical differentiated thyroid cancer: Correlation with pathologic findings. J Nucl Med. 2006, 47 (Suppl 1): 327-
Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, Busnardo B: Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med. 1993, 34: 1626-1631. PubMed
- Lung nodule detected by F-18 fluorodeoxyglucose positron emission tomography-computed tomography in patients with papillary thyroid cancer, negative 131I whole body scan, and undetectable serum-stimulated thyroglobulin levels: two case reports
- BioMed Central